MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials.

Neurobiol Aging · 2016 · PMC4827255 · PMID 26545631

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Using the brain amyloid information only, sample size estimates were significantly smaller in amyloid+ EMCI and LMCI participants, and borderline significant in AD patients, compared with amyloid− patients ( Table 6 and Fig. 6B ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.